Videos

in-Pharmatechnologist.com's review of Interphex 2012

10-May-2012 By Gareth Macdonald

in-Pharmatechnologist.com was at Interphex 2012 in New York, US to launch the revamped version of our website and speak to the pharmaceutical manufacturing and processing tech sector’s movers and shakers.

in-Pharmatechnologist @ Interphex 2012

24-Apr-2012 By Gareth Macdonald

In-Pharmatechnologist.com has chosen Interphex - the drug industry’s biggest production and processing technology show – as the launch event for our new look, refocused news website.

Parexel discusses transdermal drug delivery techs

22-Dec-2011 By Natalie Morrison

Electroporation is the wave of the future for transdermal drug delivery, according to Parexel’s Ravi Harapanhalli.

Quotient says screening of prototype formulations is crucial to drug delivery

13-Dec-2011 By Natalie Morrison

Quotient has stressed the importance of screening prototype formulations early in the development process to ensure efficient drug delivery in later phases.

Covance adding mass spec for biosimilars

23-Nov-2011 By Nick Taylor

Covance is adding mass spectrometry and other capabilities to meet growing demand for biosimilar comparability services.

“Fear of the unknown” limiting adoption of real-time release testing, FDA says

21-Nov-2011 By Nick Taylor

Real-time release testing can save money by cutting recalls but “fear of the unknown” is limiting use, a FDA official said.

Pharma must improve existing methods to boost solubility as “quantum leap” unlikely

15-Nov-2011 By Nick Taylor

To boost solubility pharma must develop, refine and improve existing methods as a “quantum leap” in formulation is unlikely, Pharmaterials' CEO said.

Patheon mulls drug delivery tech deals to accelerate development services growth

14-Nov-2011 By Nick Taylor

Patheon is considering buying unique drug delivery technologies to expand its development service capabilities.

FDA developing QbD examples to ready generic industry for 2013 deadline

10-Nov-2011 By Nick Taylor

The US FDA is publishing immediate and modified release QbD examples to help generics companies prepare for full implementation in 2013.

Catalent eyes acquisitions in emerging market and drug delivery expansion

07-Nov-2011 By Nick Taylor

Catalent is considering acquisitions as it adds scale, drug delivery technologies and capacity in emerging markets.

Pfizer & Bend collaborating on osteoarthritis nanoparticle drug delivery

03-Nov-2011 By Nick Taylor

Bend Research is developing a nanoparticle drug delivery system for treating osteoarthritis in a “close collaboration” with Pfizer.

Icon sets its sights on genomics development

31-Oct-2011 By Natalie Morrison

Icon will this year focus its R&D efforts on gaining new grounds in genomics, said Brian O’Dwyer.Icon

ImQuest Biosciences launches ARV delivery patch at AAPS

27-Oct-2011 By Natalie Morrison

A new antiretroviral (ARV) transdermal delivery patch developed at ImQuest Biosciences will wipe out the need for the “cocktail” of oral medication HIV sufferers have to take every day.